Schonfeld Strategic Advisors LLC Codexis, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.26 - $6.84 $321,630 - $516,420	-75,500 Reduced 62.81%	44,700 $208,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $81,204 - $172,324	13,400 Added 12.55%	120,200 $728,000
Q2 2022 Aug 15, 2022	SELL	$8.35 - $21.89 $1.65 Million - $4.34 Million	-198,200 Reduced 64.98%	106,800 $1.12 Million
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $1.23 Million - $2.31 Million	-72,400 Reduced 19.18%	305,000 $6.29 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $8.96 Million - $14.6 Million	349,800 Added 1267.39%	377,400 $11.8 Million
Q3 2021 Nov 16, 2021	BUY	$19.65 - $27.99 $542,340 - $772,524	27,600 New	27,600 $642,000
Q1 2019 May 15, 2019	SELL	$15.53 - $22.15 $192,572 - $274,660	-12,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.06 - $22.57 $174,344 - $279,868	12,400 New	12,400 $207,000

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $274M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.